Success with an angel syndicate: How one pharma startup raised $16M without VCs
Savara Pharmaceuticals needed several million dollars to take its inhalable drug for troublesome infections in cystic fibrosis patients through Phase 2 clinical trials. So CEO Rob Neville, naturally, began talking […]
Jun 16, 2013